Carolyn Brown

Ottawa

Writer at Freelance

Contributor at Medscape

Featured in: Favicon

medscape.com (+3) Favicon

substack.com Favicon

thetimes.co.uk Favicon

thefacts.com Favicon

gazettenet.com Favicon

audiofilemagazine.com Favicon

shepherd.com Favicon

newinbooks.com Favicon

lavozdeanza.com Favicon

booksofmyheart.net + 2 more

Articles

Un seul antiplaquettaire après TAVR réduit le risque de décès confirme une étude en vie réelle

2 days ago | francais.medscape.com | Carolyn Brown

Les patients ayant reçu un seul traitement antiplaquettaire – généralement de l'aspirine – après un remplacement valvulaire aortique transcathéter (TAVR) avaient un risque de décès dans les 6 mois suivants environ réduit de moitié par rapport aux patients ayant reçu un double traitement antiplaquettaire, selon une étude de terrain. Les résultats étaient similaires chez les hommes et les femmes et chez les patients atteints ou non d'une maladie coronarienne.
Antiagregação plaquetária única após TAVI reduz riscos

3 days ago | portugues.medscape.com | Carolyn Brown

Pacientes que receberam um único tratamento antiplaquetário — geralmente aspirina — após o implante transcateter da válvula aórtica (TAVI) apresentaram cerca de metade do risco de óbito nos seis meses subsequentes em comparação com pacientes que receberam terapia antiplaquetária dupla. Os achados foram semelhantes em homens e mulheres, e em pacientes com e sem doença arterial coronariana.
FDA Approves TAVR in Asymptomatic Severe Stenosis

1 week ago | medscape.com | Carolyn Brown

A transcatheter aortic valve replacement (TAVR) therapy was approved by the US Food and Drug Administration (FDA) for patients with severe aortic stenosis even without symptoms. This is the first FDA approval for TAVR in patients who are asymptomatic. Current clinical guidelines recommend routine surveillance every 6-12 months in patients who aren’t having any symptoms.
Single Antiplatelet After TAVR Lowers Risk

1 week ago | mdedge.com | Carolyn Brown

FROM SCAI 2025Patients who received a single antiplatelet drug therapy — usually aspirin — after transcatheter aortic valve replacement (TAVR) had about half the risk of dying in the subsequent 6 months compared with patients who received dual antiplatelet drug therapy. The findings were similar in men and women and in patients with and without coronary artery disease.
Single Antiplatelet After TAVR Lowers Risk

1 week ago | medscape.com | Carolyn Brown

Patients who received a single antiplatelet drug therapy— usually aspirin — after transcatheter aortic valve replacement (TAVR) had about half the risk of dying in the subsequent 6 months compared with patients who received dual antiplatelet drug therapy. The findings were similar in men and women and in patients with and without coronary artery disease.
Los resultados del pulsioxímetro siguen siendo poco fiables

1 month ago | espanol.medscape.com | Carolyn Brown

Las mediciones de oxígeno en sangre realizadas con pulsioxímetros en los hospitales tienden a ser inferiores a las reales, según el estudio Equiox, diseñado para evaluar la capacidad de medición de esta tecnología en personas con distintos tonos de piel. "En un estudio real de pacientes en estado crítico, el rendimiento de los oxímetros de pulso fue peor que el de las normas reguladoras", afirmó la Dra.
¿Sirve de algo tratar la deficiencia de hierro en la insuficiencia cardiaca?

1 month ago | espanol.medscape.com | Carolyn Brown

close ¿Está seguro que quiere cerrar su sesión? Los pacientes con insuficiencia cardiaca y ferropenia tratados con hierro intravenoso presentaron tasas más bajas de muerte por causas cardiovasculares u hospitalización por insuficiencia cardiaca, pero los resultados del estudio FAIR-HF2 no alcanzaron significación estadística.
No Need to Restrict Fluids in Stable Heart Failure

1 month ago | medscape.com | Carolyn Brown

Allowing patients with heart failure to drink as much fluid as they want had no negative effects on safety outcomes — including hospitalization and death — and prevented discomfort related to thirst, results of the FRESH-UP trial showed. "The study questions the benefit of fluid restriction in patients with chronic heart failure," said investigator Roland van Kimmenade, a cardiologist at Radboud University Medical Centre in Nijmegen, Netherlands.
Pulsoximeter messen den Sauerstoffgehalt oft ungenau

1 month ago | deutsch.medscape.com | Carolyn Brown

Chicago – Pulsoximeter, kleine Geräte, die an Finger, Ohrläppchen oder Zehen geklemmt werden – sind aus der klinischen Routine nicht mehr wegzudenken. Sie sollen schnell und einfach den Sauerstoffgehalt im Blut messen. Doch laut der neuen Equiox-Studie liefern sie gerade bei schwer kranken Patienten häufig unzuverlässige Ergebnisse. Das betrifft besonders Menschen mit dunkler Hautfarbe.
Canadian government says primary care by non-physicians must be publicly funded

Jan 24, 2025 | bmj.com | Carolyn Brown

News & ViewsCanadian government... Canadian government says primary care by non-physicians must be publicly funded News BMJ 2025; 388 doi: https://doi.org/10.1136/bmj.r156 Cite this as: BMJ 2025;388:r156 The federal government in Canada is taking action to protect publicly funded primary care by stamping out private services that charge patients to see a nurse practitioner.